Cytoskeletal organization in tropomyosin-mediated reversion of ras-transformation:: Evidence for Rho kinase pathway

被引:38
作者
Shah, V
Bharadwaj, S
Kaibuchi, K
Prasad, GL
机构
[1] Wake Forest Univ, Bowman Gray Sch Med, Dept Gen Surg, Winston Salem, NC 27157 USA
[2] Wake Forest Univ, Bowman Gray Sch Med, Dept Canc Biol, Winston Salem, NC 27157 USA
[3] Wistar Inst Anat & Cell Biol, Philadelphia, PA USA
[4] Nara Inst Sci & Technol, Ikoma, Japan
关键词
tropomyosin; cytoskeleton; Rho kinase;
D O I
10.1038/sj.onc.1204291
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Tropomyosin (TM) family of cytoskeletal proteins is implicated in stabilizing actin microfilaments. Many TM isoforms, including tropomyosin-1 (TM1), are downregulated in transformed cells. Previously we demonstrated that TM1 is a suppressor of the malignant transformation, and that TM1 reorganizes microfilaments in the transformed cells, To investigate how TM1 induces microfilament organization in transformed cells, we utilized uas-transformed NIH3T3 (DT) cells, and those transduced to express TM1, and/or TM2, Enhanced expression of TM1 alone, but not TM2, results in re-emergence of microfilaments; TM1, together with TM2 remarkably improves microfilament architecture. TM1 induced cytoskeletal reorganization involves an enhanced expression of caldesmon, but not vinculin, alpha -actinin, or gelsolin, In addition, TM1-induced cytoskeletal reorganization and the revertant phenotype appears to involve re-activation of RhoA controlled pathways in DT cells. RhoA expression, which is suppressed in DT cells, is significantly increased in TM1-expressing cells, without detectable changes in the expression of Pac or Cdc42, Furthermore, expression of a dominant negative Rho kinase, or treatment with Y-27632 disassembled microfilaments in normal NIH3T3 and in TM1 expressing cells. These data suggest that reactivation of Rho kinase directed pathways are critical for TM1-mediated microfilament assemblies.
引用
收藏
页码:2112 / 2121
页数:10
相关论文
共 57 条
[11]   SUPPRESSION OF TROPOMYOSIN SYNTHESIS, A COMMON BIOCHEMICAL FEATURE OF ONCOGENESIS BY STRUCTURALLY DIVERSE RETROVIRAL ONCOGENES [J].
COOPER, HL ;
FEUERSTEIN, N ;
NODA, M ;
BASSIN, RH .
MOLECULAR AND CELLULAR BIOLOGY, 1985, 5 (05) :972-983
[12]  
COOPER HL, 1987, CANCER RES, V47, P4493
[13]   SUPPRESSION OF TUMORIGENICITY IN TRANSFORMED-CELLS AFTER TRANSFECTION WITH VINCULIN CDNA [J].
FERNANDEZ, JLR ;
GEIGER, B ;
SALOMON, D ;
SABANAY, I ;
ZOLLER, M ;
BENZEEV, A .
JOURNAL OF CELL BIOLOGY, 1992, 119 (02) :427-438
[14]   SUPPRESSION OF TUMORIGENICITY IN SIMIAN-VIRUS 40-TRANSFORMED 3T3 CELLS TRANSFECTED WITH ALPHA-ACTININ CDNA [J].
GLUCK, U ;
KWIATKOWSKI, DJ ;
BENZEEV, A .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (02) :383-387
[15]   Rho GTPases and the actin cytoskeleton [J].
Hall, A .
SCIENCE, 1998, 279 (5350) :509-514
[16]   Caldesmon inhibits nonmuscle cell contractility and interferes with the formation of focal adhesions [J].
Helfman, DM ;
Levy, ET ;
Berthier, C ;
Shtutman, M ;
Riveline, D ;
Grosheva, I ;
Lachish-Zalait, A ;
Elbaum, M ;
Bershadsky, AD .
MOLECULAR BIOLOGY OF THE CELL, 1999, 10 (10) :3097-3112
[17]   TROPOMYOSIN IS DECREASED IN TRANSFORMED-CELLS [J].
HENDRICKS, M ;
WEINTRAUB, H .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES, 1981, 78 (09) :5633-5637
[18]   Caldesmon [J].
Huber, PAJ .
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY, 1997, 29 (8-9) :1047-1051
[19]  
ISHIKAWA R, 1989, J BIOL CHEM, V264, P16764
[20]  
ISHIKAWA R, 1989, J BIOL CHEM, V264, P7490